CRT0066854
CRT0066854 is a potent and selective atypical PKC isoenzymes inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively[1].
Product Specifications
CAS Number
1438881-19-6
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
PKC; ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/crt0066854.html
Concentration
10mM
Purity
99.54
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
N[C@H](CNC1=NC(C2=CC=NC=C2)=NC3=C1C(CCCC4)=C4S3)CC5=CC=CC=C5
Molecular Formula
C24H25N5S
Molecular Weight
415.55
Precautions
H315, H319, H320
References & Citations
[1]Kjær S, et al. Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes. Biochem J. 2013 Apr 15;451 (2) :329-42.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKCζ; PKC-ι ℩; ROCK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SIPD089Hu01-01 10 µg
Recombinant Cholinergic Receptor, Nicotinic, Beta 4 (CHRNb4)
Sign In for Pricing
View Details SIPD089Hu01-02 50 µg
Recombinant Cholinergic Receptor, Nicotinic, Beta 4 (CHRNb4)
Sign In for Pricing
View Details SIPD089Hu01-03 200 µg
Recombinant Cholinergic Receptor, Nicotinic, Beta 4 (CHRNb4)
Sign In for Pricing
View Details SIPD089Hu01-04 1 mg
Recombinant Cholinergic Receptor, Nicotinic, Beta 4 (CHRNb4)
Sign In for Pricing
View Details SIPD089Hu01-05 5 mg
Recombinant Cholinergic Receptor, Nicotinic, Beta 4 (CHRNb4)
Sign In for Pricing
View Details 
12106111 3x 1.0 µg
AP2A1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details